In patients with colon carcinoma (n = 262), high ANGP2 and VEGF‐A expression, individually, predicts a somewhat worse probability of survival compared to low ANGPT2 or VEGF‐A expression, whereas high or low ANGPT1, PDGFA, and FGF2 expression has no impact (Fig 2D). This evidence concerns the gene PDGFA and colon carcinoma.